Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
osu1324750762.pdf (2.28 MB)
ETD Abstract Container
Abstract Header
THE ROLE OF CD103 EXPRESSION IN PROMOTING INTESTINAL GRAFT VERSUS HOST DISEASE
Author Info
Anthony, Bryan Alan
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=osu1324750762
Abstract Details
Year and Degree
2011, Doctor of Philosophy, Ohio State University, Integrated Biomedical Science Graduate Program.
Abstract
The limiting factor to the broad use of bone marrow transplantation (BMT) to cure hematopoietic malignancy is graft verses host disease (GVHD). GVHD is caused by mature T cells present in the bone marrow graft that recognize and destroy host epithelial tissue. Mature T cells facilitate several beneficial effects including elimination of residual malignant cells, the so-called graft-vs-leukemia (GVL) effect. The goal of this work was to develop a strategy for attenuating GVHD pathology mediated by donor T cells without compromising beneficial GVL effects. During GVHD, integrins present on the surface of T cells dictate T cell localization and accumulation patterns. CD103 is an integrin that is upregulated on CD8 T cells during GVHD. Given that the only known ligand of CD103 is the epithelial-specific molecule E-cadherin, we postulated that CD103 expression is required for destruction of the gut epithelium during GVHD, but is not required for effective clearance of a blood malignancy. To test this overall hypothesis, we first characterized CD103 expression and its role in promoting GVHD pathology in the host gut in both an MHC-disparate and a clinically relevant MHC-matched GVHD model. We then assessed the capacity of donor T cells on the CD103-deficient background to mediate GVL effects. Our studies showed that CD103 expression was required for optimal accumulation of CD8 T cells in the gut epithelium. Co-depletion of iii CD4 and CD103 expressing cells completely prevented mortality following MHC-disparate BMT. Interestingly, CD103 depletion exacerbated GVHD pathology following MHC-matched GVHD induction. Adoptive transfer studies showed that T cells from CD103-deficient donors cleared malignant B cells as effectively as those from wild-type donors. Our data show a conflicting role for CD103 following BMT, however, our data suggest that CD103 expression on CD8 T cells promotes intestinal pathology, but is not required for host defense against hematopoietic malignancy. Together, these data suggest that CD103 blockade may have the potential to prevent gut GVHD pathology without compromising GVL effects.
Committee
Gregg Hadley, PhD (Advisor)
Caroline Whitacre, PhD (Committee Member)
Steven Devine, MD (Committee Member)
Viginia Sanders, PhD (Committee Member)
James Waldman, PhD (Committee Member)
Pages
138 p.
Subject Headings
Immunology
Keywords
GVHD
;
CD8 T cell
;
CD103
;
GVL
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Anthony, B. A. (2011).
THE ROLE OF CD103 EXPRESSION IN PROMOTING INTESTINAL GRAFT VERSUS HOST DISEASE
[Doctoral dissertation, Ohio State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=osu1324750762
APA Style (7th edition)
Anthony, Bryan.
THE ROLE OF CD103 EXPRESSION IN PROMOTING INTESTINAL GRAFT VERSUS HOST DISEASE.
2011. Ohio State University, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=osu1324750762.
MLA Style (8th edition)
Anthony, Bryan. "THE ROLE OF CD103 EXPRESSION IN PROMOTING INTESTINAL GRAFT VERSUS HOST DISEASE." Doctoral dissertation, Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1324750762
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
osu1324750762
Download Count:
344
Copyright Info
© 2011, all rights reserved.
This open access ETD is published by The Ohio State University and OhioLINK.